Atlas Trials

Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

Clinical trial NCT00835276 · COMPLETED

Trial details

NCT number
NCT00835276
Sponsor
Teva Pharmaceuticals USA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2002-03-01
Primary completion
2002-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.